• Explore /
  • Poster
  • / Avelumab first-line maintenance therapy for locally advanced/metastatic urothelial carcinoma: Results from the real-world US PATRIOT-II study.

Avelumab first-line maintenance therapy for locally advanced/metastatic urothelial carcinoma: Results from the real-world US PATRIOT-II study.

Abstract Poster

Authors

null

Petros Grivas

Division of Hematology & Oncology, University of Washington & Fred Hutchinson Cancer Center, Seattle, WA

Petros Grivas , Pedro C. Barata , Helen H. Moon , Shilpa Gupta , Thomas E. Hutson , Cora N. Sternberg , Jason Brown , Vaidehi Dave , Chad Downey , Alicia C. Shillington , Howard Katzenstein , Melissa Kirker , Sarah Hanson , Frank X. Liu , Valerie A. Morris , Abhijeet Bhanegaonkar , Guru P. Sonpavde

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Other

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 697)

DOI

10.1200/JCO.2024.42.4_suppl.697

Abstract #

697

Poster Bd #

L19

Abstract Disclosures

Similar Posters

First Author: Inkeun Park

First Author: Lorenzo Antonuzzo

First Author: Srikala S. Sridhar

First Author: Begoña Pérez-Valderrama